Global Nasogastric Tube Market Strategic Research Report
By Type: Levin Tube, Salem Sump Tube, Dobhoff Tube, Others
By Application: Children, Adult
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Becton Dickinson, Cardinal Health, Fresenius Kabi, B. Braun Melsungen AG, Avanos Medical, Vygon, Boston Scientific Corporation, Cook Medical, Medtronic, Baxter International, Moog, Applied Medical Technology(AMT), Rontis Medical, Nutricia, Andersen Products, Bicakcilar, GBUK Group, ConMed Corporation, Degania Silicone, Baihe Medical, Pacific Hospital Supply, Well Lead Medical, Weigao Group, Tuoren Medical Device, Pengguan Biotech, Weite Medical Equipment
개요
Scope of the Report
The global Nasogastric Tube market size is predicted to grow from US$ 287 million in 2025 to US$ 346 million in 2032; it is expected to grow at a CAGR of 2.7% from 2026 to 2032.
Nasogastric tube: A tube that is passed through the nose and down through the nasopharynx and esophagus into the stomach. Abbreviated NG tube. It is a flexible tube made of rubber or plastic, and it has bidirectional potential. It can be used to remove the contents of the stomach, including air, to decompress the stomach, or to remove small solid objects and fluid, such as poison, from the stomach. An NG tube can also be used to put substances into the stomach, and so it may be used to place nutrients directly into the stomach when a patient cannot take food or drink by mouth.
Key Findings
Standard PVC nasogastric tubes represent the largest product segment by volume
Enteral nutrition remains the primary application area for nasogastric tube products
In 2025, global sales volume of nasogastric tubes is projected to reach 16.06 million units, with a production capacity of approximately 22 million units; the average selling price is $17.39 per unit, and the average gross profit margin ranges from 35% to 45%.
Asia Pacific represents the largest volume growth region driven by expanding healthcare capacity
Market Trends
The nasogastric tube industry is gradually shifting from basic disposable gastric access products toward higher-performance enteral nutrition solutions with improved patient comfort, safety, and placement accuracy. Product development is increasingly focused on smaller diameter tubes, biocompatible materials, radiopaque designs, anti-clogging structures, and standardized connectors to improve clinical usability. Demand is also expanding from traditional hospital applications toward long-term nutritional support and home-care scenarios, encouraging manufacturers to optimize product performance while maintaining cost efficiency.
Market Dynamics
Drivers
The growth of the nasogastric tube market is primarily supported by increasing demand for enteral nutrition, rising elderly populations, higher prevalence of chronic diseases, and increasing ICU and postoperative care requirements. Expanding healthcare infrastructure in emerging markets further supports the adoption of basic and advanced nasogastric tube products.
Restraints
Market development is constrained by the mature nature of conventional nasogastric tubes, strong price competition in standard products, and limited differentiation among basic PVC-based tubes. Raw material price fluctuations and increasing regulatory requirements for medical devices also create additional manufacturing pressure.
Opportunities
Growth opportunities are emerging in polyurethane and silicone-based products, long-term feeding applications, home enteral nutrition, and specialized tubes designed for improved patient comfort and reduced complications. Integration with enteral feeding systems and demand for safer clinical procedures provide additional development opportunities.
Challenges
The industry faces challenges from intense competition among medical consumable suppliers, product commoditization, regional regulatory differences, and the need for continuous improvement in material safety and clinical performance. Manufacturers must balance higher product value with affordability requirements in healthcare systems.
Industry Chain Analysis
The nasogastric tube industry follows a medical device manufacturing value chain consisting of raw materials, catheter manufacturing, sterilization, packaging, distribution, and clinical application. Upstream suppliers provide medical-grade polymers, additives, connectors, radiopaque materials, and packaging components. The midstream segment focuses on extrusion molding, tube processing, assembly, sterilization validation, and quality control. Manufacturing efficiency, material selection, and automated production capabilities are major factors influencing cost structure and profitability.
Downstream demand mainly comes from hospitals, intensive care units, surgical departments, rehabilitation facilities, and home-care providers. Product value creation is concentrated around safety performance, patient comfort, clinical reliability, and compliance with medical device standards.
Segment Insights
The market is mainly segmented by material, application, tube design, and usage duration. PVC-based nasogastric tubes maintain the largest share due to their low cost, mature manufacturing process, and broad clinical adoption. However, polyurethane and silicone products are gaining importance in applications requiring longer retention periods, improved flexibility, and enhanced patient tolerance.
By application, enteral nutrition represents the largest segment, followed by gastric decompression and medication delivery. Higher-value products are concentrated in specialized feeding applications where material performance, positioning accuracy, and compatibility with feeding systems become key purchasing factors.
Downstream Market Opportunities
The major downstream opportunities for nasogastric tubes are concentrated in hospitals, ICU care, postoperative nutrition management, elderly care, and home enteral nutrition. Increasing demand for long-term nutritional support and improved patient management models is expected to create additional opportunities for advanced feeding tube products with better comfort and safety characteristics.
Regional Insights
Asia Pacific represents the largest volume market due to its large patient population, expanding hospital networks, and increasing demand for basic medical consumables. China and other emerging Asian markets provide significant growth opportunities through healthcare infrastructure expansion and increasing access to clinical nutrition services.
North America and Europe represent higher-value markets where demand is more concentrated on advanced materials, specialized feeding tubes, and products with improved clinical performance. Regional differences are mainly reflected in product mix, healthcare reimbursement systems, and adoption of advanced enteral nutrition technologies.
Competitive Landscape Analysis
The global nasogastric tube market is characterized by a combination of large international medical device companies and specialized disposable medical product manufacturers. Competition in standard products is mainly based on production scale, manufacturing cost, distribution capability, and regulatory compliance, while higher-end segments compete through material technology, product design, and clinical performance. The market includes companies with broad medical device portfolios as well as manufacturers focused specifically on enteral nutrition and catheter products. No single company dominates all product categories, and competitive advantages vary across regions and application segments.
This report presents a comprehensive overview of the global Nasogastric Tube market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Levin Tube
- Salem Sump Tube
- Dobhoff Tube
- Others
Segment by Material
- PVC
- Silicone
- PU
Segment by Number of Lumens
- Single-Lumen Type
- Dual-Lumen Type
- Triple-Lumen Type
Segment by Application
- Children
- Adult
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Nasogastric Tube market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Children, Adult evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Nasogastric Tube Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Levin Tube
- 3.1.3 Salem Sump Tube
- 3.1.4 Dobhoff Tube
- 3.1.5 Others
- 3.1.6 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Children
- 4.1.3 Adult
- 4.1.4 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Becton Dickinson
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Cardinal Health
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Fresenius Kabi
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 B. Braun Melsungen AG
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Avanos Medical
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Vygon
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Boston Scientific Corporation
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Cook Medical
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Medtronic
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Baxter International
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Moog
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Applied Medical Technology(AMT)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Rontis Medical
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Nutricia
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Andersen Products
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Bicakcilar
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 GBUK Group
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
- 8.18 ConMed Corporation
- 8.18.1 Company Overview
- 8.18.2 Key Products & Segments
- 8.18.3 Financial Performance (2023–2025)
- 8.18.4 Business Strategy
- 8.18.5 SWOT Analysis
- 8.18.6 Strategic Implications (2026–2032)
- 8.19 Degania Silicone
- 8.19.1 Company Overview
- 8.19.2 Key Products & Segments
- 8.19.3 Financial Performance (2023–2025)
- 8.19.4 Business Strategy
- 8.19.5 SWOT Analysis
- 8.19.6 Strategic Implications (2026–2032)
- 8.20 Baihe Medical
- 8.20.1 Company Overview
- 8.20.2 Key Products & Segments
- 8.20.3 Financial Performance (2023–2025)
- 8.20.4 Business Strategy
- 8.20.5 SWOT Analysis
- 8.20.6 Strategic Implications (2026–2032)
- 8.21 Pacific Hospital Supply
- 8.21.1 Company Overview
- 8.21.2 Key Products & Segments
- 8.21.3 Financial Performance (2023–2025)
- 8.21.4 Business Strategy
- 8.21.5 SWOT Analysis
- 8.21.6 Strategic Implications (2026–2032)
- 8.22 Well Lead Medical
- 8.22.1 Company Overview
- 8.22.2 Key Products & Segments
- 8.22.3 Financial Performance (2023–2025)
- 8.22.4 Business Strategy
- 8.22.5 SWOT Analysis
- 8.22.6 Strategic Implications (2026–2032)
- 8.23 Weigao Group
- 8.23.1 Company Overview
- 8.23.2 Key Products & Segments
- 8.23.3 Financial Performance (2023–2025)
- 8.23.4 Business Strategy
- 8.23.5 SWOT Analysis
- 8.23.6 Strategic Implications (2026–2032)
- 8.24 Tuoren Medical Device
- 8.24.1 Company Overview
- 8.24.2 Key Products & Segments
- 8.24.3 Financial Performance (2023–2025)
- 8.24.4 Business Strategy
- 8.24.5 SWOT Analysis
- 8.24.6 Strategic Implications (2026–2032)
- 8.25 Pengguan Biotech
- 8.25.1 Company Overview
- 8.25.2 Key Products & Segments
- 8.25.3 Financial Performance (2023–2025)
- 8.25.4 Business Strategy
- 8.25.5 SWOT Analysis
- 8.25.6 Strategic Implications (2026–2032)
- 8.26 Weite Medical Equipment
- 8.26.1 Company Overview
- 8.26.2 Key Products & Segments
- 8.26.3 Financial Performance (2023–2025)
- 8.26.4 Business Strategy
- 8.26.5 SWOT Analysis
- 8.26.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the size of the global Nasogastric Tube market?
What is the forecast CAGR for the Nasogastric Tube market?
What is Nasogastric Tube?
How is the Nasogastric Tube market segmented by type?
What are the key applications of Nasogastric Tube?
Which companies are profiled in the Nasogastric Tube market report?
What geographies does the Nasogastric Tube market analysis include?
What are the key demand drivers for Nasogastric Tube?
What are the main risks and barriers in the Nasogastric Tube market?
Who should buy the Nasogastric Tube market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Nasogastric Tube Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices